Biventricular Pacing and ICD: Cardiac Resynchronization Therapy for Heart Failure - pediagenosis
Article Update
Loading...

Thursday, November 12, 2026

Biventricular Pacing and ICD: Cardiac Resynchronization Therapy for Heart Failure

Medical illustration showing the benefits of biventricular pacing in ventricular resynchronization, comparing delayed ventricular activation with coordinated ventricular contraction. The diagram highlights conduction block, sinus node, atrioventricular node, improved pumping efficiency, and reduced mitral regurgitation.


BIVENTRICULAR PACING AND INTRACARDIAC DEFIBRILLATOR

Biventricular Pacing For Heart Failure

Patients with left ventricular failure often have asynchrony of the left ventricle that results in delayed lateral-wall electrical activation and mechanical contraction of the lateral LV wall, disorganized LV contraction, decreased efficiency of the LV pumping chamber, and often mitral regurgitation. ECG reveals a conduction block manifested as left bundle branch block (LBBB). When this asynchrony is related to impaired conduction, the septum may contract normally but the LV free wall may not. In general, the wider the QRS complex in LBBB, the better are the results of biventricular (BiV) pacing. The purpose of biventricular pacing is to synchronize contraction of the septum and the LV free wall (see Plate 6-138).

Thus the BiV pacing device, when working properly, is responsible for chronic resynchronization therapy. CRT organizes the ventricular activation sequence by coordinating septal free wall contraction, which improves pumping efficiency of the left ventricle, diminishes mitral regurgitation and increases cardiac output, and facilitates management of severe cardiac failure patients. In order for this device to work properly, the septum and the lateral LV wall must be viable. Thus, failure to improve ventricular function can occur in patients with lateral-wall or septal MIs.

The generator for endocardial pacing systems is inserted into a pocket commonly made below the mid- clavicle. The endocardial lead system of an atrioventricular (A-V) dual-chamber pacemaker is usually introduced through the subclavian vein, which becomes the basic pacing unit. An additional lead system is added to pace the LV free wall. The new catheter lead is introduced into the coronary sinus, then advanced to a marginal vein so that it paces the epicardial surface of the LV free wall. Thus the septum is paced by the intraventricular route from the right ventricle and the LV lateral wall is paced epicardially.

 

Medical anatomical illustration showing biventricular pacing and implantable cardiac defibrillator (ICD) placement. The diagram highlights the cardiac resynchronization therapy device, pulse generator, right atrial and ventricular leads, coronary sinus lead, active and passive fixation leads, and defibrillation coils within the heart.

Intracardiac Defibrillator In Heart Failure Patients

Patients in heart failure who are to receive a biventricular pacing device also often receive a BiV intracardiac defibrillator, or implantable cardioverter-defibrillator (ICD), because most have poor LV function (EF <35%) and are at high risk for sudden cardiac death. The ICD has become the dominant therapy for the treatment of these patients. Randomized trials have shown that ICDs reduce mortality from sudden cardiac death in those patients resuscitated from a cardiac arrest caused by ventricular tachycardia (VT). Antiarrhythmic drugs (e.g., amiodarone, sotalol) are used as adjunctive therapy to reduce frequent ICD shocks in these patients.

The ICD is similar to a typical pacemaker, but the generator is slightly larger than the usual pacemaker generator. In all aspects, the implantation procedure is similar to that of standard pacemaker implantation. The venous access and pocket for the device are the same as for a dual-chamber pacemaker: the subcutaneous region below the midclavicle. Because of the numerous functions of an implantable cardiac defibrillator (e.g., cardioverter, defibrillator, and pacemaker), the device is slightly larger than a standard pacemaker. All ICD leads have tip electrodes than can sense the heart rate and deliver an electrical stimulus to pace the heart (see Plate 6-139).

Various models of defibrillators are available. In general, when a serious arrhythmia (e.g., VT) is detected, the ICD can be programmed to “burst pace” at a rate higher than the VT. The burst pacing is then abruptly terminated, and often the VT is converted to sinus rhythm. If the device fails to convert the arrhythmia, the energy required for defibrillation will ramp up, and the patient will be shocked. All ICDs have built-in ability to interpret the device for rhythm disturbances, to determine which arrhythmia was cardioverted or shocked. Most often the device is programmed to detect a heart rate, above which the device will activate with burst pacing or shocks. Until recently, pacemakers and ICDs were not magnetic resonance compatible, but most manufacturers now are working to make MR-compatible ICDs.


Share with your friends

Give us your opinion

Note: Only a member of this blog may post a comment.

Notification
This is just an example, you can fill it later with your own note.
Done